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Abstract
Background: Gastric cancer is the fifth most common cancer worldwide. Along with environmental factors, such as
Helicobacter pylori (H. pylori) infection, genetic changes play important roles in gastric tumor formations. miR-584 is
a less well-characterized microRNA (miRNA), with apparent activity in human cancers. However, miR-584 expression
pattern in gastric cancer development has remained unclear. This study aims to analyze the expression of miR-584
in gastric cancer samples and investigates the associations between this miRNA and H. pylori infection and clinical
characteristics.
Methods: The expression level of miR-584 was studied in primary gastric cancers versus healthy control gastric
mucosa samples using the RT-qPCR method. The clinical data were analyzed statistically in terms of miR-584
expression. In silico studies were employed to study miR-584 more broadly in order to assess its expression and
find new potential target genes.
Results: Both experimental and in silico studies showed up-regulation of miR-584 in patients with gastric cancer.
This up-regulation seems to be induced by H. pylori infection since the infected samples showed increased levels of
miR-584 expression. Deeper analyses revealed that miR-584 undergoes a dramatic down-regulation in late stages,
invasive and lymph node-metastatic gastric tumors. Bioinformatics studies demonstrated that miR-584 has a
substantial role in cancer pathways and has the potential to target STAT1 transcripts. Consistent with the inverse
correlation between TCGA RNA-seq data of miR-584 and STAT1 transcripts, the qPCR analysis showed a significant
negative correlation between these two RNAs in a set of clinical samples.
Conclusion: miR-584 undergoes up-regulation in the stage of primary tumor formation; however, becomes down-
regulated upon the progression of gastric cancer. These findings suggest the potential of miR-584 as a diagnostic
or prognostic biomarker in gastric cancer.
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Background
Gastric cancer, as the fifth most common malignancy, is
the third cause of cancer-related death worldwide in both
genders [1]. The pathogenesis of gastric cancer involves
both genetics and environmental parameters [2]. A declin-
ing trend of gastric cancer incidence over the last decades
obviously shows the significance of lifestyle, e.g. widespread
food refrigeration rather than salt as the main form of pres-
ervation [3], and environmental factors, such as Helicobac-
ter pylori (H. pylori) eradication. H. pylori infection is one
of the noticeable correlated factors with gastric neoplasm
through modulating inflammatory signaling pathways in
the mucosa of the stomach. This infection can promote the
risk of gastric cancer more than six-fold [4, 5].
Genetically, microRNAs (miRNAs) are important mol-
ecules that are deregulated in gastric cancer [6–9]. miR-
NAs are an emerging class of non-coding RNAs
containing less than 24 nucleotides, which bind mainly
to the 3′-UTR of their target mRNAs. These molecules
play a role as post-transcriptional regulatory factors
through either mRNA degradation or transcriptional re-
pression of the targeted mRNAs [10]. miRNAs contrib-
ute to determining cell fate by means of regulating
cellular processes such as proliferation and apoptosis
[11]. Inevitably, dysregulation of miRNAs displays their
association with various pathological effects, such as in-
flammatory process and precancerous lesions to malig-
nancy progression [12, 13]. Notably, H. pylori infection
is one of the vital factors responsible for miRNA dysreg-
ulation through regulating the inflammatory mediators
[14–17]. miR-21 [18, 19], miR-25 [19], miR-93 [20],
miR-146a [21], miR-155 [22], miR-196 [23], miR-200b/c
[15, 24], miR-222 [25], miR-223 [20], miR-584 and miR-
1290 [26] are the well-known H. pylori-induced up-
regulated miRNAs, while let-7b [24, 27], miR-103 [24],
miR-370 [28], miR-371, miR-372, miR-373 [29], miR-
375 [24] and miR-449 [30] are the down-regulated ones.
More recently, miR-584 has been reported to be up-
regulated in intestinal metaplasia and human primary colon
cancer tissues, induced by the H. pylori infection. miR-584,
in turn, promotes the epithelial-mesenchymal transition
(EMT) via targeting FOXA1 gene [26]. Dysregulation of
miR-584 has been also reported in gastric cancer [31]. How-
ever, there is a scientific gap regarding the expression of
miR-584 in gastric cancer in the context of H. pylori infec-
tion. Therefore, the main aim of this study was to evaluate
the expression level of miR-584 in normal gastric mucosa
specimens along with malignant gastric mucosa tissue pa-
tients and analyze its association with H. pylori infection.
Methods
Patients and control samples
Tumor samples (n = 26) were obtained from the patients
undergoing gastrectomy surgery at Al-Zahra Hospital,
Isfahan, Iran, and Kashani Hospital, Shahre Kord, Iran.
In addition, endoscopy samples (n = 11) were taken from
healthy volunteers and used as control samples. Immedi-
ately after obtaining tissue samples, they were sub-
merged in a 2 ml RNase-free containing RNAlater™
Stabilization Solution (Ambion, Austin, Texas) and
transferred to a laboratory on ice for subsequent ana-
lyses. Before specimen collection, the stomach biopsies
were taken to detect H. pylori infection using Rapid Ure-
ase Detection test (HelicotecUT Plus, Taiwan) in both
patient and control groups. The normal/tumor status of
the samples was verified by four expert pathologists.
Ethically, the samples were collected in accordance with
the guidelines issued by the Ethics Committee of Al-
Zahra Hospital, regarding 1964 Helsinki declaration.
Moreover, informed consent was gained from all studied
individuals. The characteristics of the samples including
age, sex and H. pylori infection are listed in Table 1.
RNA extraction
Total RNA from tissue specimens was extracted using
Hybrid-R™ miRNA kit (GeneAll, Seoul, South Korea).
The quality of extracted RNAs determined according to
260/280 absorbance ratio, measured by the NanoDrop
spectrometer (Thermo Scientific, USA). In order to re-
move potential DNA contamination, small RNA samples
underwent RNA-free DNase (TaKaRa, Japan) treatment.
cDNA synthesis and RT-qPCR
Normal cDNA synthesis was performed by RevertAid
Reverse Transcriptase (Thermofisher) according to the
manufacturer’s protocol. STAT1 primers were designed
with Oligo Primer Analysis software (DBA Oligo, Inc.)
as Forward: 5′-TGAACTTACCCAGAATGCCC-3′, and
Reverse: 5′-CAGACTCTCCGCAACTATAGTG-3′.
cDNA synthesis for miR-584 and U6 (reference con-
trol) was achieved by using a Universal cDNA Synthesis
Kit (Exiqon, Denmark), according to manufacturer’s in-
struction. Real-time quantitative PCR reactions were car-
ried out in triplicate by using standard protocols with an
ABI PRISM 7500 instrument (Applied Biosystems,
USA). cDNA products were added to a master mix com-
prising 10 pmol/μl of each miR-584 and U6 primers
Table 1 Patient sample characteristics
Variable Control (n = 11) Case (n = 26) p
Age (SD) 49.73 (21.45) 61.13 (13.54) 0.055 *
Sex Woman 4 6 0.406 **
Man 7 20
H. pylori infection Negative 5 12 0.969 **
Positive 6 14
SD Standard deviation, H. pylori Helicobacter pylori
* Independent t-test
** Chi-square test
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(Exiqon, Denmark) and 2 U of SYBR premix ExTaq II
(TaKaRa, Japan). Real-time data were evaluated and re-
ported based on 2-ΔΔCT method to calculate the fold
change in miR-584 expression among different groups.
The PCR program conditions were: 95 °C for 5 min
(min) followed by 40 cycles of 95 °C for 5 s (s), 60 °C for
20 s and 72 °C for 30 s.
Statistical analysis
All statistical analyses were performed by SPSS statistical
software, version 20.0 (SPSS Inc., Chicago, IL, USA).
ANOVA test was used and followed by analyzing with a
non-parametric Mann– Whitney post hoc test to evaluate
and assess the potential of miR-584 as a diagnostic indica-
tor of disease severity to differentiate between gastric malig-
nancy and normal tissue with regards to H. pylori infection.
Linear regression analysis was performed to analyze the re-
lationship between stages and survival rates to miR-584 ex-
pression in human gastric cancers. Results were considered
as statistically significant at P values equal or less than 0.05.
In silico analyses
The TCGA data (https://www.cancer.gov/tcga) were ana-
lyzed to examine the expression levels of miR-584 in paired
tumor and adjacent control samples of stomach adenocar-
cinoma patients. Besides, ENCORI (starBase) publicly avail-
able online tool [32] was used to analyze the differential
expression of miR-584 in normal and tumor samples, and
also to analyze the correlation between miR-584 and its
host and predicted target genes. The KM Plotter database
was used to investigate the survival rate of clinical patients
in terms of the expression level of miR-584 [33].
In order to perform molecular enrichment analysis on
miR-584 targetome and to determine the signaling path-
ways that are statistically involved, we used several on-
line databases of miRWalk [34] and miRTarBase [35, 36]
to achieve predicted and validated targets of miR-584
particularly. Next, using UniGene database (http://www.
ncbi.nlm.nih.gov/unigene/) and subsequent EST profile,
we investigated the filtered targetome expression in the
stomach and gastrointestinal tumors. Finally, miR-584
targetome expressed in stomach and gastrointestinal
tumor was assigned to the database for annotation,
visualization and integrated discovery (DAVID) online
bioinformatics database, version 6.7 [37] arranged with
Kyoto Encyclopedia of Genes and Genomes (KEGG)
pathway analysis [38] to recognize the most statistical
correlated signaling pathways and molecular networks
with miR-584 targetome.
Results
miR-584 is highly expressed in tumor samples
The expression level of miR-584 was determined by RT-
qPCR, followed by the statistical analysis in four groups,
including patients with H. pylori infection (n = 14), pa-
tients without H. pylori infection (n = 12), control sam-
ples infected by H. pylori (n = 6) and non-infected
control samples (n = 5). The expression pattern of miR-
584 was normalized to U6. Primer specificity for miR-
584 and U6 was evaluated by agarose gel electrophoresis
(Supplementary Figure1). Our analyses revealed that
miR-584 expression was approximately 5.3 times higher
in gastric cancer cases as compared to the control sam-
ples (P < 0.001) (Fig. 1a). The differential expression of
miR-584 was further studied using publicly available on-
line tools of TCGA and ENCORI. Analyzing the TCGA
data of stomach adenocarcinoma in the paired case-
control samples significantly showed the upregulation of
miR-584 (adjusted P < 0.001) (Fig. 1b). Consistently, the
analysis of unpaired samples in ENCORI databased re-
vealed significant and obvious higher expression of miR-
584 in the tumor samples (adjusted P < 0.001) (Fig. 1c).
Taken together, the in silico data strongly demonstrate
the overexpression of miR-584 overexpression in gastric
cancer samples, which has been validated in our study
on the clinical specimens. The TCGA data were further
studied to find whether miR-584 up-regulation is medi-
ated by epigenetic alteration or amplification. First, we
demonstrated that miR-584 is located in the intronic re-
gion of SH3TC2 gene. The transcription of these two
genes might be regulated by the same promoter region
as SH3TC2 was also shown to be up-regulated in gastric
cancer (P = 1.7e-8) (Fig. 1d), which significantly and
strongly correlated with miR-584 in gastric (P = 1.79e-
75, r = 0.774) (Fig. 1e) and other panels of human can-
cers (Supplementary Figure 2). The TCGA gene copy
number analysis revealed that SH3TC2 gene up-
regulation is not mediated by gene amplification nor epi-
genetic alterations. These data collectively suggest that
SH3TC2 gene, and thereby its intronic miR-584, are up-
regulated in cancer probably in response to the higher
expression/activity of their transcription factors. The
ChIP-seq data obtained from the UCSC genome browser
showed that SH3TC2/miR-584 locus is regulated by c-
Jun and c-Fos transcription factors, which are known
up-regulated oncoproteins in gastric cancer [39, 40].
miR-584 expression is affected by H. pylori infection
Dividing the samples in terms of H. pylori infection, the
data significantly showed a statistically elevated expres-
sion of miR-584 in the H. pylori-infected patients in
comparison with other groups including H. pylori-in-
fected controls (P = 0.018), non-infected controls (P =
0.007) and H. pylori-negative patients (P = 0.011). How-
ever, there was no significant differences between the
miR-584 expression in H. pylori-negative patients and H.
pylori-infected controls (P = 0.609) or non-infected con-
trols (P = 0.054) (Fig. 2a). Comparing the control
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samples, although the expression of miR-584 increased
slightly in the H. pylori-infected samples, the difference
was not significant (P = 0.928) (Fig. 2a). Furthermore and
independent of tumor/control status, miR-584 was
expressed significantly higher in H. pylori-infected samples
as compared to non-infected ones, with approximately 2.6
fold change increase (P = 0.005) (Fig. 2b). To examine this
hypothesis in another cohort, the TCGA samples, that had
been recently tested for H. pylori infection using the
methods described in the Zhang et al. study [41], were then
analyzed in terms of miR-584 expression. Likewise, this
analysis displayed a significant correlation between H. pylori
Fig. 1 a Analysis of miR-584 expression in the patient’s tumor versus normal tissue. b In silico analysis of miR-584 in paired TCGA clinical gastric
cancer and normal gastric mucosa samples. c In silico analysis of miR-584 in unpaired TCGA clinical gastric cancer samples. d Analysis of SH3TC2
expression in the patient’s tumor versus normal tissue. e Correlation between miR-584 and SH3TC2 expression gastric cancer samples.
*** P < 0.005
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infection and miR-584 expression (P = 0.034) (Fig. 2c). Col-
lectively, the findings suggest that the elevated expression
of miR-584 could be driven by H. pylori infection in gastric
cancer. It remains to be validated whether H. pylori infec-
tion can up-regulate miR-584 in gastric cancer based on
in vitro assays.
miR-584 does not correlate with the patients’
demographics
We then asked whether the expression of miR-584 cor-
relates with the age, blood group or the sex of the stud-
ied patients. Our analyses showed no significant
correlation or association between either age (P = 0.309),
sex (P = 0.745) or blood groups (P = 0.774). Next, we in-
terrogated whether miR-584 is associated with the clin-
ical features of gastric cancer patients.
Association of miR-584 expression level and
clinicopathological factors
To delineate the clinical significance of miR-584, we an-
alyzed the correlation between miR-584 levels and the
patient’s clinicopathological factors in greater detail. To
study the potential correlation with gastric cancer stages,
all tumor samples were reviewed by the pathologist after
Hematoxylin & Eosin (H&E) staining and were catego-
rized into different clinical stages (I-IV) based on AJCC/
UICC Tumor Node Metastasis (TNM) staging system.
Interestingly, there was a significant difference be-
tween the expression level of miR-584 in different sta-
ging groups, including stage I and III (P = 0.048), I and
IV (P = 0.030), and II and IV (P = 0.038) (Fig. 3a). Fur-
thermore, linear regression analyses showed that miR-
584 expression was negatively correlated with gastric
malignancy stages, in a way that the expression level of
Fig. 2 a Analysis of miR-584 expression in four H. pylori-categorized normal and tumor samples. b Analysis of miR-584 expression in H. pylori-
positive and negative samples. c Analysis of miR-584 expression in H. pylori-categorized TCGA clinical samples. * P < 0.05, ** P < 0.01, *** P < 0.005
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this miRNA was higher in the early stages of gastric can-
cer and it decreased in the progression of malignancy
(P < 0.001, Spearman test) (Fig. 3b). The high-
throughput analysis of TCGA data also revealed a simi-
lar trend, i.e. elevated miR-584 expression in early and
lower expression in the higher stages (Fig. 3c). These re-
sults suggest that this miRNA could be specifically a
cancer-promoting factor which undergoes down-
regulation during cancer progression. In line with this
finding, higher expression of miR-584 was shown to be
associated significantly with the absence of regional
lymph node metastases, in comparison with lymph node
metastatic samples (P = 0.005) (Fig. 3c). Interestingly, we
did find a significant difference of miR-584 expression in
Fig. 3 a Analysis of miR-584 in different gastric cancer stages. b Correlation of miR-584 and different stages of gastric cancer samples. c Analysis
of miR-584 expression in different gastric cancer stages of TCGA gastric cancer samples. d Analysis of miR-584 in lymph node-negative and
positive gastric tumors. e Analysis of miR-584 among tumors with different regional lymph node involvement. f Analysis of miR-584 expression
among gastric tumors with different depths of invasion. * P < 0.05, ** P < 0.01
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N0 level, as compared to N2 (P = 0.001) and N3 (P =
0.001). Additionally, the expression of miR-584 in N1
groups was different from N2 (P = 0.028) and N3 (P =
0.002). Nevertheless, there were no significant differ-
ences between N0 and N1 (P = 0.306) or N2 and N3
(P = 0.129) (Fig. 3d).
Moreover, evaluation of the miR-584 expression and
the degree of invasion to the gastric wall showed a
significant difference in T1 vs. T3 (P = 0.004) and T4
(P = 0.009); but not to T2 (P = 0.931). Furthermore, a sig-
nificant different expression of miR-584 was observed
when comparing T2 to T3 (P = 0.021) and T4 (P =
0.003), and T3 to T4 (P = 0.008). (Fig. 3e). Collectively,
the miR-584 expression pattern reveals that this small
non-coding RNA is highly expressed upon the formation
of gastric tumors. However, its regulation declines sig-
nificantly with the progression of cancer.
These provocative findings prompted us to check
whether miR-584 correlates with the higher survival rate
of the patients. Linear regression analysis revealed clear
segregation of survival rates between the four staging
groups (Fig. 4a). The regression curve demonstrates a
strong correlation between miR-584 level and 5-year
survival rate of the patients. To assess this finding in a
larger population, KM Plotter online tool was used. Ana-
lyzing the survival rate of 431 stomach adenocarcinoma
patients clearly showed that higher expression of miR-
584 is correlated with lower overall survival of the pa-
tients (Log rank P = 0.05, hazard ratio = 0.72, 95% CI:
0.50–1.03) (Fig. 4b). Further analyses revealed that pa-
tients with a higher expression of miR-584 survived for
median of 56.2 months, while the patients with a low ex-
pression only survived for a median of 26.7 months.
More interestingly, studying the patients with stage IV
of adenocarcinoma showed a greater effect of miR-584
expression (Log rank P = 0.032, hazard ratio = 0.32, 95%
CI: 0.11–1.96) (Fig. 4c). Hypothetically, although miR-
584 is dramatically up-regulated in primary gastric tu-
mors, it undergoes down-regulation upon the progres-
sion of cancer, contributing to the higher stages and
lower survival of the patients. The schematic proposed
role of miR-584 in gastric cancer initiation and progres-
sion is shown in Fig. 4d.
Computational analysis of miR-584 targetome proposed a
possible inducing role of miR-584 in cancer
To help define how miR-584 may be related to gastric
cancer, molecular signaling pathway enrichment analysis
as already described in the materials and methods was
performed. Using miRTarBase and miRwalk databases,
112 and 1552 mRNAs were specified as validated and
predicted targets of miR-584, respectively (data not
shown). Among the list, 65 validated and 670 predicted
mRNA targets were reported to be expressed in stomach
and gastrointestinal tumors, achieved from the UniGene
database. These target genes were selected as miR-584
targetome for further molecular enrichment analysis.
Imputing Entrez IDs as official gene symbols of selected
miR-584 targetome into the functional annotation tool
of DAVID determined the statistically significant associ-
ation of imputed genes with several KEGG signaling
pathways. The set of imputed genes representing the
miR-584 targetome was chiefly associated with several
KEGG signaling pathways showing that target genes
were significantly involved in cancer pathways and other
oncogenic/tumor suppressor transduction systems in-
cluding Wnt signaling, TGF-β signaling, adherence junc-
tion and VEGF signaling pathways (Table 2). The
enriched KEGG pathways in cancer are shown in Sup-
plementary Figure 3. Interestingly, among these targets,
EST1 and MAPK1 are validated targets of miR-584 as
reported by experimental technology evidence. STAT1,
PTEN, CCND1 and PIK3CA genes were among the top-
score unvalidated miR-584 targetome. In silico correl-
ation analysis performed via ENCORI database revealed
that there were significant inverse correlations between
miR-584 and these transcripts (Fig. 5a-d). STAT1 was
selected for correlation analysis in 10 gastric cancer and
5 normal gastric mucosa in-house clinical samples due
to its highest r value. Interestingly, qPCR analysis and
Spearman’s correlation test showed a significant negative
correlation between miR-584 and STAT1 transcript ex-
pression (r = − 0.551, P = 0.033) (Fig. 5e). Taken together,
miR-584 may have an unvalidated cancer-related targe-
tome that includes PTEN, CCND1, PIK3CA and STAT1.
The latter showed a negative correlation in both TCGA
and in-house clinical samples. The end-point in vitro val-
idation using luciferase reported assay remains to be per-
formed to validate the predicted targetome of miR-584.
Discussion
There are emerging reports pertaining to the pathogen-
esis capabilities of miRNAs in cancer. Such studies have
demonstrated the great importance of miRNAs as diag-
nostic/prognostic biomarkers with therapeutic potential.
Among several miRNAs, a number of studies reported
the association between miR-584 with different cancers
such as lung [42], breast [43] and neuroblastoma [44].
Consistent with these findings, miR-584 may contribute
to other malignancies such as gastric cancer.
In an effort to elucidate the role of miR-584 in gastric
cancer - for the first time and to the best of our know-
ledge - we performed a case-control study and evaluated
miR-584 expression level in 26 cases and 11 controls of
the non-neoplastic gastric mucosa. Furthermore, in silico
analyses obtained by the publicly available online tools
were employed to assess the key findings.
Ebrahimi Ghahnavieh et al. BMC Cancer          (2020) 20:621 Page 7 of 12
Analysis of the expression of miR-584 in gastric tumor
and healthy stomach tissues showed that miR-584 is sig-
nificantly up-regulated in the primary gastric cancer tis-
sues. The in silico studies on the paired and unpaired
samples significantly displayed the miR-584 expression
in gastric cancer patients. We further analyzed the in-
house and TCGA data and showed that the up-
regulation of miR-584 could be mediated by H. pylori in-
fection since the infected samples showed higher expres-
sion of miR-584 significantly. Interestingly, the known
H. pylori-induced transcription factors, c-Jun and c-Fos
[45, 46], were shown to be the potential miR-584 tran-
scription drivers. Collectively, we propose H. pylori ➔ c-
Jun/c-Fos ➔ miR-584 route as a proposed mechanistic
Fig. 4 a Survival analysis of miR-584 expression in four different gastric tumor stages. b In silico survival analysis of miR-584 expression in clinical
gastric cancer subjects. c In silico survival analysis of miR-584 expression in patients with stage IV of gastric cancer. d Proposed schematic of miR-
584 expression pattern in gastric cancer development
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route of miR-584 up-regulation in gastric cancer. This
hypothesis remained to be further studied and validated
by in vitro biochemical experiments.
Despite the miR-584 expression up-regulation in gas-
tric cancer patients, the analyses of low versus high-
grade tumor samples clearly showed that the expression
of miR-584 undergoes down-regulation upon the pro-
gression of gastric cancer. miR-584 has indeed lower ex-
pression in higher stages, invasive and lymph node
metastatic samples. Interestingly, the bioinformatics
studies on the survival rate of gastric cancer subjects re-
veal that the patients with higher expression of miR-584
survived for a longer time. These findings suggest that
miR-584 overexpression might be required for gastric
tumorigenesis, while it has to be down-regulated upon
tumor progression. Further in vitro biochemical studies
are highly recommended through which the biological
functions such as cell growth and invasion of gastric
cancer cell lines can be examined upon miR-584 overex-
pression and downregulation. Narasimhan et al. reported
the up-regulation of miR-584 in colorectal cancer.
Interestingly, the higher expression of this miRNA was
only observed in colon adenoma and not carcinoma. In
line with our findings, this study supports that miR-584
overexpression is only required for the primary levels of
tumorigenesis [47].
As discussed before, we showed that there is a signifi-
cantly higher miR-584 expression in H. pylori-infected
samples, especially in tumors. Consistent with our find-
ing, Zhu et al. demonstrated the NFκB-mediated up-
regulation of miR-584 in response to H. pylori infection,
which in turn resulted in the induction of intestinal
metaplasia of gastric epithelial cells [26]. Furthermore,
miR-584 up-regulation could also be driven in Porphyro-
monas gingivalis infection and inflammatory diseases
[48, 49]. These findings strongly indicate that miR-584
could be an important downstream target of inflamma-
tory and pathogenic stimuli, contributing to stomach
tumorigenesis. Performing in-situ hybridization of miR-
584 in the sections including proper gastric gland, intes-
tinal metaplasia and gastric cancer tissue can further
prove this finding.
Table 2 Top statistically related signaling pathways to miR-584 targetome obtained from KEGG database through DAVID tool
Rank KEGG Pathway Number of genes (%) P*
1 Pathways in cancer 21 (2.9) 5.4E2
2 Regulation of actin cytoskeleton 19 (2.6) 3.4E3
3 Focal adhesion 17 (2.4) 9.1E3
4 Ubiquitin mediated proteolysis 15 (2.1) 1.6E3
5 Chemokine signaling pathway 14 (1.9) 4.7E2
6 Endocytosis 13 (1.8) 8.1E2
7 Fc gamma Rmediated phagocytosis 12 () 1.8E3
8 Chronic myeloid leukemia 11 (1.7) 9.9E4
9 Insulin signaling pathway 11 (1.5) 5.4E2
10 Wnt signaling pathway 11 (1.5) 9.8E2
11 Pancreatic cancer 10 (1.4) 2.8E3
12 Adherens junction 10 (1.4) 4.4E3
13 Vascular smooth muscle contraction 9 (1.2) 9.4E2
14 Colorectal cancer 9 (1.2) 2.3E2
15 TGFbeta signaling pathway 9 (1.2) 2.8E2
16 Oocyte meiosis 9 (1.2) 8.7E2
17 Longterm potentiation 8 (1.1) 2.2E2
18 Phosphatidylinositol signaling system 8 (1.1) 3.4E2
19 Endometrial cancer 7 (1) 2.0E2
20 Acute myeloid leukemia 7 (1) 3.3E2
21 Melanoma 7 (1) 7.4E2
22 B cell receptor signaling pathway 7 (1) 9.1E2
23 VEGF signaling pathway 7 (1) 9.1E2
24 Nonsmall cell lung cancer 6 (0.8) 7.3E2
25 Dorsoventral axis formation 4 (0.6) 8.4E2
* The threshold of EASE score, a modified Fisher Exact P-value, for gene-enrichment analysis
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Controversially, Li et al. reported that miR-584 plays a
role as a tumor suppressor miRNA in gastric cancer. In
this study, the down-regulation of miR-584 was shown
and the biochemical in vitro studies revealed that miR-584
inhibits the proliferation rate via targeting WW domain-
containing E3 ubiquitin-protein ligase 1 (WWP1), which
triggers the TGF-β signaling pathway [31]. However, they
did not clearly specify the stage/grade, and more
importantly, the status of H. pylori infection of the studied
samples.
Although some miR-584 target transcripts have been
validated, such as WWP1 and ROCK1 [50], many other
potential targets are yet to be studied. Our in silico in-
vestigations have introduced a new subset of genes that
can be potentially targeted by miR-584. Among them,
STAT1, PTEN, PI3K and cyclin D1 are the most
Fig. 5 In silico correlation of miR-584 and (a) STAT1, (b) CCND1, (c) PIK3CA and (d) PTEN expression levels in TCGA samples. e Correlation of
miR-584 and STAT1 expression levels in 5 normal gastric mocusa and 10 gastric cancer clinical samples
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interesting targets. Our in silico analysis showed a sig-
nificant negative correlation between miR-584 and either
of the genes. The negative correlation of miR-584 and
STAT1 was further validated by analyzing 15 samples
using qPCR method. These genes have remained to be
validated by biochemical in vitro studies in the future.
This can be achieved by cloning the 3’UTR of the genes
downstream of luciferase and investigate the luciferase
activity upon overexpression or knockdown of miR-584.
Conclusion
miR-584 has a fluctuating expression level in a normal stom-
ach, primary tumors and progressed gastric cancer. This
miRNA undergoes up-regulation in the early stages of pri-
mary tumor formation; however, it becomes down-regulated
upon the progression of gastric cancer. These findings
propose the potential of miR-584 as a diagnostic biomarker
for early detection of gastric cancer and a prognostic factor
to predict the clinical outcomes of the patients. The former
can be studied by analyzing the miR-584 in the serum or sal-
iva of gastric cancer and healthy individuals to determine
whether this dysregulated molecule could serve as a diagnos-
tic circulating miRNA in high-risk people.
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Supplementary information accompanies this paper at https://doi.org/10.
1186/s12885-020-07116-5.
Additional file 1 Supplementary Figure 1. Analysis of RT-qPCR prod-
ucts of miR-584 and U6 primers separated by agarose gel electrophoresis.
Additional file 2 Supplementary Figure 2. Correlation between miR-
584 and SH3TC2 expression in a panel of human cancers including (A)
brain lower grade glioma, (B) head and neck squamous cell carcinoma,
(C) lung squamous cell carcinoma, (D) kidney renal papillary cell carcin-
oma, (E) skin cutaneous melanoma and (F) lung adenocarcinoma.
Additional file 3 Supplementary Figure 3. miR-584 targetome is in-
volved in several important pathways including cancer pathways as well
as Wnt signaling, TGF-beta signaling, adherence junction and VEGF sig-
naling pathways, ranked as top related signaling pathways. The diagram
collected from KEGG pathway. The unvalidated potential targets of miR-
584 are marked by red asterisks.
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